Objectives:
1. To discuss and inform about hydrobromide–quinidine sulfate use for Alzheimer disease–related agitation
2.To assess the efficacy, safety, and tolerability of dextromethorphan hydrobromide–quinidine sulfate for Alzheimer disease–related agitation.
Session date:
05/12/2016 - 8:00am to 9:00am CDT
Location:
UCMC
W-717
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Samir Bhalla, MD